Research Article

The Apolipoprotein B/Apolipoprotein A-I Ratio as a Potential Marker of Plasma Atherogenicity

Table 2

The plasma lipids and apolipoproteins in the groups with apoB/apoA-I<0.9 () and apoB/apoA-I>0.9 ().

Group with
apoB/apoA-I<0.9
Group with
apoB/apoA-I>0.9
value

Age, years35.0 (29.0; 43.0)39.0 (30.0; 47.0)0.185
Body mass index, kg/m224.7 (22.7; 26.5)24.8 (21.9; 25.7)0.813
TC, mmol/L4.12 (3.55; 4.64)4.24 (3.58; 4.73)0.825
TG, mmol/L1.05 (0.85; 1.34)1.34 (1.06; 1.65)0.004
HDL-C, mmol/L1.40 (1.21; 1.55)1.41 (1.25; 1.58)0.420
LDL-C, mmol/L2.30 (1.66; 2.70)2.10 (1.60; 2.64)0.478
Non-HDL-C, mmol/L2.74 (2.14; 3.26)2.71 (2.06; 3.28)0.943
TC/HDL-C 2.93 (2.50; 3.51)2.92 (2.36; 3.25)0.538
ApoA-I, mg/dL152.6 (115.0; 188.0)102.6 (73.0; 122.4)<0.001
ApoB, mg/dL71.0 (53.0; 89.0)147.9 (98.9; 190.0)<0.001
ApoB/apoA-I0.48 (0.38; 0.62)1.36 (1.07; 1.61)<0.001
ApoE, mg/dL2.81 (2.00; 3.55)2.19 (1.23; 2.96)0.011
LDL-C/apoB1.16 (0.88; 1.59)0.61 (0.43; 0.69)<0.001
AIP−0.10 (−0.23; −0.01)−0.05 (−0.15; 0.04)0.032

Values are presented as the median and interquartile range. The Mann-Whitney test was used to estimate differences between the groups.